RxDoctor Payments Data

Lanna Smith, NP

Nurse Practitioner · Arlington, VANPI 1366515561

Payments from drug & device makers

$1,348in general payments, 2019–2025

Across 61 payments — averaging $22.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$269
  • Amgen$263
  • Pfizer$157
  • Merck$127
  • Scpharmaceuticals Inc.$107
  • E.r. Squibb & Sons, L.L.C.$84
  • plus $341 from 10 others

What the payments were for

  • Food & beverage$1,32098%
  • Education$282%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,348 in reported general payments places this provider in the 85th percentile of 2,166 nurse practitioner providers in Virginia.

See all nurse practitioner providers in Virginia

Medicare billing

Part B allowed, 2024
$12,305
Medicare patients
96
Services billed
190

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban181$249,069
EntrestoSacubitril/Valsartan35$54,929
JardianceEmpagliflozin33$54,616
XareltoRivaroxaban38$49,987
Repatha SureclickEvolocumab37$45,352
BrilintaTicagrelor12$13,062
Ranolazine ErRanolazine35$6,051
Metoprolol Succinate272$4,853
Atorvastatin Calcium137$1,496
Midodrine Hcl12$1,469
Rosuvastatin Calcium106$1,450
Valsartan37$1,333
Hydralazine Hcl23$1,127
Amlodipine Besylate129$1,034
Nebivolol Hcl13$992

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$157$249,069181 claims
NovartisEntresto$269$54,92935 claims
Boehringer IngelheimJardiance$21$54,61633 claims
Johnson & JohnsonXarelto$62$49,98738 claims
AstraZenecaBrilinta$45$13,06212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,166 nurse practitioner providers in Virginia.

Other nurse practitioner in Arlington

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →